Bluejay Diagnostics (BJDX) Enterprise Value (QoQ) (2020 - 2026)
Bluejay Diagnostics (BJDX) Enterprise Value (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn |
| 10 | Bluejay Diagnostics | 1.04 Mn | 1.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.66% |
| Dec 31, 2025 | -67.57% |
| Sep 30, 2025 | 30.63% |
| Jun 30, 2025 | -42.58% |
| Mar 31, 2025 | 27.57% |
| Dec 31, 2024 | 25.83% |
| Sep 30, 2024 | 28.03% |
| Jun 30, 2024 | -202.81% |
| Mar 31, 2024 | -20.50% |
| Dec 31, 2023 | 56.50% |
| Sep 30, 2023 | 0.46% |
| Jun 30, 2023 | 24.79% |
| Mar 31, 2023 | 32.95% |
| Dec 31, 2022 | 23.89% |
| Sep 30, 2022 | 13.38% |
| Jun 30, 2022 | 10.41% |
| Mar 31, 2022 | 10.10% |
| Dec 31, 2021 | -717.45% |
| Dec 31, 2020 | 326.67% |